ACADIA Pharmaceuticals, Inc. (ACAD)
26.76
-0.68
(-2.48%)
USD |
NASDAQ |
Dec 08, 16:00
26.74
-0.02
(-0.07%)
After-Hours: 20:00
ACADIA Pharmaceuticals Total Liabilities (Quarterly): 413.50M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 135.14M |
| ADMA Biologics, Inc. | 137.50M |
| Aldeyra Therapeutics, Inc. | 28.56M |
| Amicus Therapeutics, Inc. | 638.39M |
| ANI Pharmaceuticals, Inc. | 902.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.331B |
| Shareholders Equity (Quarterly) | 917.27M |
| Debt to Equity Ratio | 0.0598 |
| Current Ratio | 3.019 |
| Net Debt Paydown Yield | 0.02% |